SBI Securities Co. Ltd. Invests $244,000 in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

SBI Securities Co. Ltd. bought a new position in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,708 shares of the company’s stock, valued at approximately $244,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Dunhill Financial LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth about $46,000. Spire Wealth Management bought a new position in Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter valued at approximately $68,000. B. Riley Wealth Advisors Inc. bought a new position in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at approximately $279,000. SG Americas Securities LLC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 6.0% in the 4th quarter. SG Americas Securities LLC now owns 3,392 shares of the company’s stock valued at $305,000 after buying an additional 193 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 129.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,851 shares of the company’s stock valued at $625,000 after buying an additional 2,735 shares during the last quarter.

Direxion Daily S&P Biotech Bull 3x Shares Trading Up 5.7 %

Shares of NYSEARCA LABU opened at $79.09 on Thursday. The company has a 50 day simple moving average of $89.96 and a 200 day simple moving average of $112.23. Direxion Daily S&P Biotech Bull 3x Shares has a 1 year low of $69.69 and a 1 year high of $164.74.

Direxion Daily S&P Biotech Bull 3x Shares Profile

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.